[Clinical trial of a new fluorinated pyrimidine, 5'-deoxy-5-fluorouridine (5'-DFUR)]. 1986

A Hoshino, and K Ohara, and O Kamiya, and K Nagata, and Y Ono, and A Kawakubo, and Y Ozaki, and A Suzuki, and T Ogasawara, and I Sugiura

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D001859 Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. Bone Cancer,Cancer of Bone,Cancer of the Bone,Neoplasms, Bone,Bone Neoplasm,Neoplasm, Bone
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D005467 Floxuridine An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract. FUdR,Fluorodeoxyuridine,5-FUdR,5-Fluorodeoxyuridine,5 Fluorodeoxyuridine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A Hoshino, and K Ohara, and O Kamiya, and K Nagata, and Y Ono, and A Kawakubo, and Y Ozaki, and A Suzuki, and T Ogasawara, and I Sugiura
May 1985, Gan no rinsho. Japan journal of cancer clinics,
A Hoshino, and K Ohara, and O Kamiya, and K Nagata, and Y Ono, and A Kawakubo, and Y Ozaki, and A Suzuki, and T Ogasawara, and I Sugiura
October 1987, Gan to kagaku ryoho. Cancer & chemotherapy,
A Hoshino, and K Ohara, and O Kamiya, and K Nagata, and Y Ono, and A Kawakubo, and Y Ozaki, and A Suzuki, and T Ogasawara, and I Sugiura
December 1985, Gan to kagaku ryoho. Cancer & chemotherapy,
A Hoshino, and K Ohara, and O Kamiya, and K Nagata, and Y Ono, and A Kawakubo, and Y Ozaki, and A Suzuki, and T Ogasawara, and I Sugiura
June 1983, Nihon Gan Chiryo Gakkai shi,
A Hoshino, and K Ohara, and O Kamiya, and K Nagata, and Y Ono, and A Kawakubo, and Y Ozaki, and A Suzuki, and T Ogasawara, and I Sugiura
October 1985, Gan to kagaku ryoho. Cancer & chemotherapy,
A Hoshino, and K Ohara, and O Kamiya, and K Nagata, and Y Ono, and A Kawakubo, and Y Ozaki, and A Suzuki, and T Ogasawara, and I Sugiura
December 2005, Gan to kagaku ryoho. Cancer & chemotherapy,
A Hoshino, and K Ohara, and O Kamiya, and K Nagata, and Y Ono, and A Kawakubo, and Y Ozaki, and A Suzuki, and T Ogasawara, and I Sugiura
January 2000, Breast cancer (Tokyo, Japan),
A Hoshino, and K Ohara, and O Kamiya, and K Nagata, and Y Ono, and A Kawakubo, and Y Ozaki, and A Suzuki, and T Ogasawara, and I Sugiura
November 1985, Gan to kagaku ryoho. Cancer & chemotherapy,
A Hoshino, and K Ohara, and O Kamiya, and K Nagata, and Y Ono, and A Kawakubo, and Y Ozaki, and A Suzuki, and T Ogasawara, and I Sugiura
August 2005, Cancer chemotherapy and pharmacology,
A Hoshino, and K Ohara, and O Kamiya, and K Nagata, and Y Ono, and A Kawakubo, and Y Ozaki, and A Suzuki, and T Ogasawara, and I Sugiura
January 2006, Breast cancer (Tokyo, Japan),
Copied contents to your clipboard!